Capecitabine, DNA/RNA Synthesis Inhibitor

Por um escritor misterioso
Last updated 04 fevereiro 2025
Capecitabine, DNA/RNA Synthesis Inhibitor
Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.
Capecitabine, DNA/RNA Synthesis Inhibitor
5-Fluorouracil
Capecitabine, DNA/RNA Synthesis Inhibitor
5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)
Capecitabine, DNA/RNA Synthesis Inhibitor
XELODA® - Cancer Therapy Advisor
Capecitabine, DNA/RNA Synthesis Inhibitor
Mechanism of thymidylate synthase inhibition by
Capecitabine, DNA/RNA Synthesis Inhibitor
DNA/RNA合成阻害 DNA/RNA Synthesis Inhibition
Capecitabine, DNA/RNA Synthesis Inhibitor
Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response
Capecitabine, DNA/RNA Synthesis Inhibitor
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients
Capecitabine, DNA/RNA Synthesis Inhibitor
APExBIO - Capecitabine
Capecitabine, DNA/RNA Synthesis Inhibitor
Genes, Free Full-Text
Capecitabine, DNA/RNA Synthesis Inhibitor
Cells, Free Full-Text

© 2014-2025 auu.com.mx. All rights reserved.